3 Dividend Stocks That Pay You More Than Exxon Does
Looking for big yield? ExxonMobil has it, but these three stocks should also be on your radar.
GlaxoSmithKline
GSK
GSK
$1,605.60
$0.13
0.8%
BATS BZX Real Time Price as of June 25, 2019, 11:00 a.m.
View Interactive GSK Charts
GlaxoSmithKline is one of the world's leading pharmaceutical research companies. The company was created out of the merger between GlaxoWellcome and SmithKline Beecham in 2000.
News & Analysis: GlaxoSmithKline
The Fool has written over 100 articles on GlaxoSmithKline.
A Big Pharma Sex Tape Compounds China Woes
GlaxoSmithKline's troubles in China just won't go away
Sex, Drugs, and China Woes
GlaxoSmithKline is accused in China of a massive bribery scheme.
What These Ratios Tell Us About GlaxoSmithKline
Roland Head asks whether now is the right time to buy GlaxoSmithKline.
Is It Still Safe to Buy GlaxoSmithKline?
In this strong market, should you still buy GlaxoSmithKline?
The Beginners' Portfolio: What's Been Happening to Vodafone, Tesco, and GlaxoSmithKline?
We catch up on news from Vodafone, Tesco, and GlaxoSmithKline.
3 Things to Loathe About GlaxoSmithKline
Do these three things make GlaxoSmithKline a poor investment?
Why I Think GlaxoSmithKline Is So Much More Than Just an Income Stock
Often viewed as just a boring income stock, GlaxoSmithKline offers significant growth potential.
3 Things You Need to Know About GlaxoSmithKline
Before you invest another penny in GlaxoSmithKline, let's look at cash flow, debt and dividends.
Neil Woodford's Latest Buys and Sells
Examining Woodford's massive decisions on Vodafone, G4S, and AstraZeneca.
